Home: I reread Ron's response to the shareholders... he didn't need to say he disagreed with the FDA nor did he have to say he contacted his regulatory counsel to confirm the language is correct... in this instance, it doesn't make a bit of difference what Ron or the lawyer felt was correct... the fact is the FDA didn't like the language... it wasn't a matter for discussion... Ron should have simply stated something like "we have addressed the FDA's concern by changing the language on our website"... nothing more nothing less... my opinion of the CEO and certainly the regulatory attorney went down more than a few notches over this deal...
No news anywhere. Expect shorts to gang up soon. Wouldn't be surprised if the king of the shorts Adam Feuerstein takes a shot at KERX. He was short before the DNDN explosion and the smart shorts got out after a nice gain.
look at most biotech websites and their clams to their drugs and safety. All the same. It is kind of weird that Kerx is ready to announce enrollment reached and that should cause a pop! Hold strong there is more to come. Shorts are stuck!
...and I have to say, Screw the FDA! Keryx makes the claims of safety and efficacy ONLY in the context the clinical trials that it has run. Based on clinical evidence so far, Perifosine is safe and effective. This is the FDA flexing muscles and showing how a government agency can destroy value. How much market cap was lost today because of a stupid letter related to a NON-EVENT?